A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors
Clinical trial NCT04972981 · COMPLETED
Trial details
- NCT number
- NCT04972981
- Sponsor
- ADC Therapeutics S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2024-09-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.